(Q45600695)

English

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus (English)

1 reference

Europe PubMed Central

14 December 2017

1 reference

based on heuristic

inferred from title

swine influenza

1 reference

based on heuristic

inferred from title

author name string

Ronald D Wesley

1

1 reference

Europe PubMed Central

14 December 2017

Min Tang

2

1 reference

Europe PubMed Central

14 December 2017

Kelly M Lager

3

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

22

1 reference

Europe PubMed Central

14 December 2017

3427-3434

1 reference

Europe PubMed Central

14 December 2017

25-26

1 reference

Europe PubMed Central

14 December 2017

Evolution of swine H3N2 influenza viruses in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

The emergence of novel swine influenza viruses in North America

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Prevalence of swine influenza virus subtypes on swine farms in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Purified influenza virus nucleoprotein protects mice from lethal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Adenovirus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Efficacy of replication-defective adenovirus-vectored vaccines: protection following intramuscular injection is linked to promoter efficiency in muscle representative cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

A highly attenuated host range-restricted vaccinia virus strain, NYVAC, encoding the prM, E, and NS1 genes of Japanese encephalitis virus prevents JEV viremia in swine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Study of the delivery of the gD gene of pseudorabies virus to one-day-old piglets by adenovirus or plasmid DNA as ways to by-pass the inhibition of immune response by colostral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Single inoculation of replication-defective adenovirus-vectored vaccines at birth in piglets with maternal antibodies induces high level of antibodies and protection against pseudorabies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Identification of a 17000 molecular weight antigenic polypeptide in transmissible gastroenteritis virus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.02.040

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2004.02.040

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45600695&oldid=2102542108"